FPH launches new Evora compact nasal mask for sleep apnea

News Release
STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH)
Fisher & Paykel Healthcare launches new Evora™ compact nasal mask for sleep
apnea
Auckland, New Zealand, 3 February 2020 – Fisher & Paykel Healthcare Corporation Limited
announced today the launch of F&P Evora™, a new nasal mask for the treatment of
obstructive sleep apnea (OSA).
F&P Evora is a compact nasal mask that sits comfortably under the nose. The mask features
CapFit™ headgear, which is designed to be put on like a baseball cap in one simple and
intuitive movement. In a clinical trial*, 98 per cent of participants described Evora as “simple
to take off and put on in the dark,” and 95 per cent of respiratory therapists found the mask
“simple to fit.”
Evora also features a ‘floating’ seal, which sits inside stability wings. These technologies
work together to allow for freedom of movement during sleep while keeping the mask
comfortably in place.
“Evora offers OSA patients the performance benefits of a nasal mask, with the streamlined
design and minimalism of a nasal pillow mask,” said Lewis Gradon, Managing Director and
CEO of Fisher & Paykel Healthcare. “Its unique and innovative features make fitting the
mask much easier for the patient and the respiratory therapist. We’re excited to bring it to
market.”
F&P Evora will initially be available in Australia and New Zealand from February, followed by
Canada and Europe. It will be launched in other countries upon receiving clearances.
Evora has one-sized headgear and four seal sizes – small, medium, large and wide. For
more information, visit www.fphcare.com/evoranasal.
*20 out of 21 respiratory therapists rated the simplicity of the Evora nasal mask as very simple or simple to fit. Internal validation study conducted
with 21 respiratory therapists in United States of America 2019. 43 out of 44 participants were able to put on and take off the Evora nasal mask,
once fitted, in the dark. Internal validation study conducted with 44 participants in United States of America 2019.

About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and
systems for use in respiratory care, acute care, surgery and the treatment of obstructive
sleep apnea. The company’s products are sold in over 120 countries worldwide. For more
information about the company, visit our website www.fphcare.com.

Contact:

Investors:
Hayden Brown
Investor Relations Manager
hayden.brown@fphcare.co.nz
+64 27 807 8073
Media:
Karen Knott
Senior Communications Manager
karen.knott@fphcare.co.nz
+64 21 713 911